Amicus Therapeutics Inc at Goldman Sachs Global Healthcare Conference Transcript
Good morning. My name is Maryana Breitman. I am a biotech analyst at Goldman Sachs. And firstly, I will read the disclaimer. We're required to make certain disclosures in public appearances about Goldman Sachs' relationships with companies that we discuss. The disclosures relate to [national] banking relationships, compensation received of 1% or more ownership. We're prepared to read out our disclosures for any issue or upon request. However, these disclosures are available in our most recent reports available to you as required on our firm's portal. Disclosures and updates to those disclosures are also available by ticker on the firm's public website. Also the news stated by non-Goldman Sachs personnel do not necessarily reflect those of Goldman Sachs.
It is my pleasure to welcome John Crowley, Chairman and Chief Executive Officer of Amicus Therapeutics. Thanks, John.
Maryana, good morning.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |